Getinge (OTCMKTS:GNGBY) Stock Rating Lowered by Zacks Research

Getinge (OTCMKTS:GNGBY) was downgraded by Zacks Research from a “strong-buy” rating to a “hold” rating in a research report issued on Thursday, Zacks reports.

A number of other analysts have also recently commented on the stock. Nordea Equity Research cut shares of Getinge from a “buy” rating to a “hold” rating in a research report on Monday, August 31st. UBS Group assumed coverage on Getinge in a research note on Wednesday, September 2nd. They issued a “hold” rating for the company. Three equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold”.

Getinge Stock Down 1.3%

Getinge stock opened at $23.93 on Thursday. The firm has a market capitalization of $6.52 billion, a price-to-earnings ratio of 22.79 and a beta of 0.93. The company’s 50 day simple moving average is $24.58 and its 200 day simple moving average is $21.93. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.31 and a quick ratio of 0.74. Getinge has a fifty-two week low of $18.99 and a fifty-two week high of $25.98.

Getinge (OTCMKTS:GNGBY) last issued its earnings results on Friday, July 17th. The company reported $0.38 EPS for the quarter. The firm had revenue of $894.87 million during the quarter. Getinge had a net margin of 7.81% and a return on equity of 11.12%. As a group, sell-side analysts anticipate that Getinge will post 1.38 EPS for the current year.

About Getinge

Getinge AB is a Sweden-based medical technology company that develops products and solutions for hospitals, healthcare providers and life science organizations. Founded in 1904 in Getinge, Sweden, the company serves customers through operations and sales channels across Europe, North America, Asia-Pacific and other international markets.

Getinge organizes its business around Acute Care Therapies, Life Science and Surgical Workflows. Its offerings include ventilators, anesthesia systems, patient monitoring and cardiovascular support technologies, as well as equipment used in intensive care and other acute-care settings.